12:00 AM
 | 
Oct 12, 2009
 |  BC Week In Review  |  Company News  |  Deals

SurModics, Roche deal

Roche and its Genentech Inc. unit received an exclusive license from SurModics to use its biodegradable microparticles drug delivery system to develop and commercialize sustained...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >